These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27916294)

  • 1. High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer.
    Zhu J; Ma J; Wang X; Ma T; Zhang S; Wang W; Zhou X; Shi J
    Transl Oncol; 2016 Dec; 9(6):592-599. PubMed ID: 27916294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer.
    Jia XQ; Zhang S; Zhu HJ; Wang W; Zhu JH; Wang XD; Qiang JF
    Transl Oncol; 2016 Jun; 9(3):191-6. PubMed ID: 27267836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer.
    Xian Y; Zhang S; Wang X; Qin J; Wang W; Wu H
    Onco Targets Ther; 2016; 9():5553-60. PubMed ID: 27660473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma.
    Zhang H; Kong W; Zhao X; Xie Y; Luo D; Chen S
    BMC Med Genomics; 2023 Feb; 16(1):29. PubMed ID: 36803157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer.
    Song Z; Feng C; Lu Y; Lin Y; Dong C
    Gene; 2018 Feb; 642():43-50. PubMed ID: 29128633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of phosphoglycerate dehydrogenase in breast cancer.
    Chandrika M; Chua PJ; Muniasamy U; Huang RYJ; Thike AA; Ng CT; Tan PH; Yip GW; Bay BH
    Breast Cancer Res Treat; 2021 Apr; 186(3):655-665. PubMed ID: 33625616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014 Apr; ():. PubMed ID: 24712844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.
    Jin E; Wang W; Fang M; Wang W; Xie R; Zhou H; Ye J; Xu R; Ma S
    Oncol Lett; 2019 Jan; 17(1):502-507. PubMed ID: 30655793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of small ubiquitin-like modifier proteases 1 predicts chemo-sensitivity and poor survival in non-small cell lung cancer.
    Mu J; Zuo Y; Yang W; Chen Z; Liu Z; Tu J; Li Y; Yuan Z; Cheng J; He J
    Chin Med J (Engl); 2014; 127(23):4060-5. PubMed ID: 25430449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.
    Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J
    Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.
    Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J
    Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.
    Cai Q; Huang Z; Qi L; Wang T; Shen Y; Huang J
    Oncol Lett; 2016 Oct; 12(4):2680-2685. PubMed ID: 27698842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.